The proceeds will support the execution of the Phase II/III trial and potential NDA submission for the Nectero EAST System, a Breakthrough Therapy for small to medium-sized AAA. TEMPE, ...
IRVINE, Calif., Feb. 18, 2025 /PRNewswire/ — Esperto Medical™, Inc. a healthtech startup specializing in critical care and remote patient monitoring, announces the closing of an oversubscribed ...
The MarketWatch News Department was not involved in the creation of this content. SARASOTA, Fla., Jan. 13, 2026 /PRNewswire/ -- Confianza, a comprehensive data and predictive analytics company, today ...